Finesse Solutions, LLC announces OPC connectivity with Nova BioProfile 400

March 7, 2008 — /PRNewswire/ — SANTA CLARA, CA — Finesse Solutions, LLC, a manufacturer of measurement and control solutions for life sciences process applications, and Nova Biomedical, Waltham, MA, a world leader in biotechnology process monitoring, announce the first TruBioTM OS plug-in for OPC connectivity between TruBio OS and Nova BioProfile 400, 100 Plus, Basic 4, and Basic 2 analyzers. Both companies confirmed that a TruBio OS plug-in for OPC connectivity to the Nova Flex is currently in development.

OPC (openness, productivity, and collaboration) has become the de facto standard for data exchange in process control systems. It has been adopted by the majority of the control system manufacturers in the bioprocess industry and has proven to be a reliable method for sharing information across different hardware platforms.

Automatic data exchange using OPC between a lab analyzer and control system reduces errors and time delays of manual sampling, and provides automated reporting of results. It also allows the control system to adjust process parameters without a 24/7 operator present and, in the event of process alarm conditions, alerts off-site personnel and/or takes automatic corrective action.

This level of integration enables direct consolidation of off-line lab analyzer results into existing historical data collection, automates batch report generation, and creates a complete electronic record. Printouts of standalone analyzer results do not have to be manually attached or tracked with electronic batch reports that control systems already provide.

“Taking advantage of OPC connectivity between Nova analyzers and the Finesse bioprocess control system will improve quality and yield, while reducing operating costs. For example, programming a Nova analyzer to automatically standardize an in situ probe, or using the resulting sample data in real-time control algorithms, will increase both process understanding and control accuracy,” states Dr. Mark Selker, CTO and co-founder of Finesse.

“By redefining the standard associated with offline data to include complete integration and the value of those data as they are applied to the bioprocess automatically, Nova and Finesse continue to provide the cutting edge technology required to bring the biotechnology industry into a new era of effectiveness and profitability. The value lies in the actions upon that information. Nova and Finesse provide the compliment to each other’s technologies, thereby allowing our customers real-time benefits that, until now, were impossible,” says Bob Fox, director of sales.

About Finesse Solutions, LLC

California-based Finesse Solutions, LLC leads the way in developing new measurement and control technologies in order to enable the transition to single-use systems, bring new capabilities to existing bioreactor platforms, and harmonize global bio-process information transfer. Its current product family provides comprehensive measurement and control solutions for upstream processes in the biotech and pharmaceutical industries.


About Nova Biomedical

Nova Biomedical is committed to continuing its technology leadership with advanced products that provide better, faster diagnostic information. The company continues to innovate biotechnology instruments that allow faster, more economical development of drugs and other therapeutic products.



Easily post a comment below using your Linkedin, Twitter, Google or Facebook account. Comments won't automatically be posted to your social media accounts unless you select to share.